Several naturally occurring mutations of ghrelin receptor , such as A204E and F279L, decrease the basal activity of the receptor and have been found to associate with obesity, diabetes, and short stature 14 , which led to the idea of ghrelin receptor being an attractive therapeutic target for these diseases
Without insurance: Out-of-pocket costs for brand-name GLP-1s can be high: Ozempic: $900$1000/month Wegovy: $499/month (with a limited-time $199 first-month offer) Zepbound: $349$499/month depending on dose If these are unaffordable, Ro may prescribe compounded semaglutide instead
Diabetes itself is a major risk factor for NAION
The peptide testing process verifies these purity claims through third-party analysis
For example, when prescribing Wegovy, RTBC might not only display cost ($0 with PA or $1800 without) but also indicate PA REQUIRED on-screen
The general principle in most protocols is to begin with a low amount, monitor tolerance, and adjust gradually, ideally under professional guidance rather than starting with higher doses
